Panagora Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Panagora Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-849,041	Closed	-$1.09M	–	1629
2022 Q1	$1.09M	Buy	849,041 +244,100	+40%	+$225K	0.01%	894
2021 Q4	$768K	Buy	604,941 +17,648	+3%	+$31.6K	﹤0.01%	1042
2021 Q3	$1.28M	Sell	587,293 -9,620	-2%	-$26.3K	0.01%	858
2021 Q2	$2.24M	Buy	596,913 +400,475	+204%	+$1.39M	0.01%	675
2021 Q1	$640K	Buy	196,438 +180,098	+1,102%	+$646K	﹤0.01%	1217
2020 Q4	$56K	Buy	16,340 +1,764	+12%	+$7.26K	﹤0.01%	2021
2020 Q3	$59K	Hold	14,576	–	–	﹤0.01%	1973
2020 Q2	$49K	Sell	14,576 -55,683	-79%	-$162K	﹤0.01%	1982
2020 Q1	$163K	Sell	70,259 -215,282	-75%	-$589K	﹤0.01%	1523
2019 Q4	$1.04M	Sell	285,541 -213,745	-43%	-$1.73M	﹤0.01%	1040
2019 Q3	$4.14M	Sell	499,286 -76,580	-13%	-$619K	0.02%	509
2019 Q2	$4.96M	Buy	575,866 +39,348	+7%	+$352K	0.02%	503
2019 Q1	$5.74M	Buy	536,518 +103,152	+24%	+$1.1M	0.03%	472
2018 Q4	$3.79M	Sell	433,366 -253,289	-37%	-$3.23M	0.02%	551
2018 Q3	$11.5M	Buy	686,655 +73,618	+12%	+$1.59M	0.04%	332
2018 Q2	$12.8M	Buy	613,037 +13,862	+2%	+$257K	0.05%	299
2018 Q1	$9.64M	Sell	599,175 -8,900	-1%	-$176K	0.04%	368
2017 Q4	$11.5M	Sell	608,075 -73,661	-11%	-$1.33M	0.04%	360
2017 Q3	$9.59M	Sell	681,736 -90,237	-12%	-$816K	0.04%	417
2017 Q2	$5.75M	Sell	771,973 -204,794	-21%	-$1.34M	0.02%	534
2017 Q1	$6.35M	Buy	976,767 +139,641	+17%	+$781K	0.03%	524
2016 Q4	$3.71M	Buy	837,126 +27,277	+3%	+$114K	0.02%	649
2016 Q3	$3.78M	Sell	809,849 -152,318	-16%	-$902K	0.02%	646
2016 Q2	$6.32M	Sell	962,167 -149,637	-13%	-$1.06M	0.03%	481
2016 Q1	$7.07M	Buy	1,111,804 +240,330	+28%	+$1.23M	0.04%	462
2015 Q4	$5.25M	Buy	871,474 +124,979	+17%	+$715K	0.03%	534
2015 Q3	$4.46M	Buy	746,495 +75,210	+11%	+$522K	0.02%	536
2015 Q2	$4.59M	Buy	671,285 +2,314	+0.3%	+$14.7K	0.02%	546
2015 Q1	$4.06M	Buy	668,971 +311,519	+87%	+$2.07M	0.02%	565
2014 Q4	$2.48M	Buy	357,452 +13,209	+4%	+$97.1K	0.01%	674
2014 Q3	$2.8M	Sell	344,243 -7,908	-2%	-$61.9K	0.01%	650
2014 Q2	$2.86M	Buy	352,151 +153,062	+77%	+$1.16M	0.01%	696
2014 Q1	$1.56M	Buy	199,089 +77,176	+63%	+$653K	0.01%	976
2013 Q4	$1.08M	Buy	121,913 +46,561	+62%	+$416K	0.01%	1146
2013 Q3	$632K	Sell	75,352 -10,684	-12%	-$86.5K	﹤0.01%	1278
2013 Q2	$642K	Buy	+86,036	New	+$660K	﹤0.01%	1219

Other funds holding SPPI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Panagora Asset Management's SPPI Position: Q2 2022 in Review

Panagora Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 849,041 shares — an estimated $1.09M sold.

Panagora Asset Management first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $12.8M in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

Panagora Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
Panagora Asset Management sold 849,041 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $1.09M.
Panagora Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
Panagora Asset Management's Spectrum Pharmaceuticals Inc position peaked at $12.8M in Q2 2018.
86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.